Compound Detail
CHEMBL2016681
VELNEPERIT 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL2016681 |
| Name | VELNEPERIT |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | WGEWUYACXPEFPO-AULYBMBSSA-N |
2
Targets
3
Activities
2
Assay Types
1
PK Parameters
15
Publications
2
Known Names
1
Indications
1
Mechanisms
Molecular Properties
407.5
MW (Da)
3.32
ALogP
4
HBA
2
HBD
88.2
PSA (Ų)
0.80
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Neuropeptide Y receptor type 5 antagonist | ANTAGONIST | Neuropeptide Y receptor type 5 | ✓ | ✓ |
Indications
Obesity
Activity Summary
IC50 2 meas. best 8.34
Ki 1 meas. best 8.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Neuropeptide Y receptor type 5 CHEMBL3802 | IC50 | 8.34 | 8.34 | 4.6 | 2 |
| Neuropeptide Y receptor type 5 CHEMBL4561 | Ki | 8.3 | 8.3 | 5.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 5.75 | uL.min-1.(10^6cells)-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Neuropeptide Y receptor type 5 | IC50 | = | 4.6 | nM | 8.34 | Displacement of [125I]PYY from mouse NPY Y5 receptor | 23025998 |
| Neuropeptide Y receptor type 5 | IC50 | = | 4.6 | nM | 8.34 | Displacement of [125I]PYY from mouse NPY-Y5 receptor | 23206862 |
| Neuropeptide Y receptor type 5 | Ki | = | 5.0 | nM | 8.3 | Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in ins... | 22445286 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3301361 | ADMET | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 22445286 | 10.1016/j.bmcl.2012.02.098 | Neuropeptide Y receptor type 5 | 1 |
| 23025998 | 10.1016/j.bmcl.2012.09.025 | Neuropeptide Y receptor type 5 | 1 |
| 23025998 | 10.1016/j.bmcl.2012.09.025 | No relevant target | 1 |
| 23206862 | 10.1016/j.bmcl.2012.11.005 | No relevant target | 1 |
| 23206862 | 10.1016/j.bmcl.2012.11.005 | Cytochrome P450 3A4 | 1 |
| 23206862 | 10.1016/j.bmcl.2012.11.005 | Cytochrome P450 2D6 | 1 |
| 23206862 | 10.1016/j.bmcl.2012.11.005 | Cytochrome P450 2C9 | 1 |
| 23206862 | 10.1016/j.bmcl.2012.11.005 | Cytochrome P450 2C19 | 1 |
| 23206862 | 10.1016/j.bmcl.2012.11.005 | Cytochrome P450 1A2 | 1 |
| 23206862 | 10.1016/j.bmcl.2012.11.005 | Neuropeptide Y receptor type 5 | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
Data from ChEMBL 36 via Core Engine